Skip to main content
Egyptian Pediatric Association Gazette
Download PDF

Attention-deficit hyperkinetic disorder among children and adolescents with type 1 diabetes: a cross-sectional study

Egyptian Pediatric Association Gazette volume 70, Article number: 54 (2022) Cite this article

Abstract

Background

Type 1 diabetes is a common childhood disease that is affected by and affects every aspect in the life of the child or adolescent with diabetes. Data on attention-deficit hyperkinetic disorder (ADHD) among children and adolescents with type 1 diabetes is limited. The aim of this study was to assess the prevalence of ADHD among a cross-sectional sample of 70 children and adolescents with type 1 diabetes as compared to 70 matched controls and to assess the glycemic control of included patients. For a comprehensive evaluation, assessment was done using Pediatric Symptom Checklist (PSC, the 35 item), Diagnostic and Statistical Manual of Mental Disorders—the fifth edition (DSM-5) criteria, and Conners comprehensive behavior rating scale—revised for parents/caregivers. Glycemic control of all included patients was also evaluated by HbA1c %.

Results

A screening PSC score was significantly higher for children and adolescents with type 1 diabetes than controls (p < 0.001). Significantly larger number of cases with type 1 diabetes fulfilled DSM-5 criteria for inattentive or hyperactive or mixed type ADHD (14.3%, 17.1% and 18.6%, respectively) as compared to controls (4.3%, 5.7%, and 7.1% respectively, p < 0.05). Also, a significantly larger number (more than half, 57.14%) had a Conners score above 70, and the mean scores on Conners parent rating scale were also significantly higher for children with type 1 diabetes than controls (p < 0.001). Most of the included patients did not achieve adequate glycemic control (47.14% of patients were in poor control and only about one fifth achieved a HbA1c < 7.5%).

Conclusion

ADHD is more common among children and adolescents with type 1 diabetes than in healthy controls. It is important to perform psychiatric evaluation of children and adolescents with type 1 diabetes especially those in poor metabolic control to assess for associated neuro-behavioral disorders such as ADHD. This is crucial to be able to properly design insulin therapy for such a group of patients who may suffer hypo- or hyper-glycemia due to inattention, forgetfulness, or hyperactivity and to properly select educational material that take the easy distractibility of ADHD patients into account as well as to be able to properly manage such cases given the extra stresses entailed in having a diagnosis of diabetes.

Background

Type 1 diabetes mellitus (T1DM) is one of the most common chronic diseases of children and adolescents. Type 1 diabetes affects and is affected by every aspect of a child’s life (food, exercise, psychological status). Therefore, psychological assessment and support of individuals with diabetes is essential for successful management of their diabetes.

Attention-deficit hyperkinetic disorder (ADHD) is one of the most common neuro-behavioral disorders of childhood. ADHD was shown to have increasing global prevalence in recent decades [1]. The core ADHD symptoms are inattention and/or hyperactivity/impulsivity. These core symptoms must cause impairment of functioning in at least two settings (academic, social or occupational) for a diagnosis of ADHD to be established [2]. ADHD has a multifactorial etiology. In most cases, it results from the additive effect of multiple genetic and environmental risk factors acting together to increase the susceptibility of the individual to develop ADHD. Besides genetic predisposition, environmental risk factors that have been associated with ADHD include maternal deprivation, growing up in a stressful environment, prenatal and perinatal factors (such as maternal smoking and alcohol use), low birth weight, premature birth, and exposure to environmental toxins (such as organophosphate pesticides, polychlorinated biphenyls, zinc, and lead) [3].

Recent research has shown that among children with type 1 diabetes, a diagnosis of neurodevelopmental disorders, primarily ADHD and intellectual disability, was associated with poor glycemic control [4]. It was even suggested that a diagnosis of ADHD should be considered in adolescents with type 1 diabetes who are in poor glycemic control [5]. In one prospective research study, increased risk of diagnosis of comorbid psychiatric disorders was reported among children and adolescents with type 1 diabetes (with a 1.5 hazard ratio for ADHD) as compared to non-diabetic controls. The highest risk of psychiatric disorders was found to occur within the first 6 months of diagnosis of T1DM, and it declined with time afterwards [6]. ADHD among children and adolescents with type 1 diabetes can have a profound effect on their diabetes management and be affected by their diabetes control.

Not every child or adolescent with type 1 diabetes is evaluated by a psychiatrist in our diabetes clinic. Therefore, in the current study, we aimed to screen for the presence of ADHD symptoms using Pediatric Symptom checklist, DSM-5 criteria, and standardized Conners parent rating scale among children and adolescents with type 1 diabetes attending the out-patient diabetes clinic and to explore their glycemic control. We compared them to a matched control group.

Methods

Study design

Our study was a cross-sectional study. It was carried out in the period between October 2019 and October 2020.

Participants

Children and adolescents with type 1 diabetes aged 6 to 16 years old were randomly recruited from the Pediatric Diabetes Clinic of Ain Shams University Children’s’ Hospital. These children and adolescents were randomly selected using simple random sampling from the clinic data base. Type 1 diabetes was diagnosed if the patient was not obese, had no signs of insulin resistance, no family history suggestive of MODY (monogenic or maturity onset diabetes of the young), had low C-peptide, and showed insulin dependency on the doses required for a T1DM patient. Autoantibody testing is performed at our center if any of the aforementioned criteria is not fulfilled. Patients who did not have any of the exclusion criteria were first extracted from the clinic database. Next, from those patients, a sample was randomly selected for inclusion in the study using a simple random technique by means of a random number generator software. Exclusion criteria included having any neurologic disease, developmental disorder, learning disability, hearing or visual impairment, sleep disorder, specific emotional or behavioral disorders (e.g., anxiety, depressive, oppositional defiant, and conduct disorders), thyroid disease or any other chronic illness (other than diabetes), or having a positive family history of ADHD or other psychiatric disorder. Moreover, psychiatric evaluation was not done following recent recovery from diabetic ketoacidosis.

Age and sex-matched healthy controls were recruited from the outpatient clinic of the Ain Shams University Children’s’ Hospital. They were either coming for their scheduled vaccinations or to follow-up their growth.

A required sample size of 70 cases with type 1 diabetes and 70 controls was calculated using the Epitools program setting to detect an alpha error at 5% and power at 80%.

Data collected and study tools

Data on history of diabetes mellitus duration, current age and age at onset of diabetes, dosage of insulin, method of insulin delivery, and HbA1c average over the 6 month-period prior to inclusion in the study were collected. Diabetes control was classified as follows: good control if HbA1c < 7.5%, borderline if HbA1c is between 7.5 and < 9%, and poor control if at or above 9%. This is based on the American Diabetes Association guidance and the International Society of Pediatric and Adolescent Diabetes (ISPAD) guideline [7] advising such higher HbA1c goal if there is lack of access to advanced insulin delivery technology and continuous glucose monitoring (CGM) for the child with diabetes [7].

Psychometric assessment for ADHD

The following assessments were used in evaluating possible ADHD diagnosis among children and adolescents with type 1 diabetes and controls:

  1. A.

    Pediatric Symptom Checklist (PSC)—the Arabic validated version [8].

  2. B.

    Diagnostic and Statistical Manual of Mental Disorders—the fifth edition (DSM-5) criteria. DSM-5 criteria are the standard criteria used based on the best available evidence for ADHD diagnosis [9, 10]. The Arabic validated version was used [11].

  3. C.

    Conners comprehensive behavior rating scale—revised for parents/caregivers: the Arabic validated version [12].

A. Pediatric Symptom Checklist (PSC)—parent version

This is a brief, 35-item, questionnaire designed to screen for cognitive/attention, emotional, and behavioral problems in children and adolescents and is meant to provide an assessment of psychosocial functioning. Although psychosocial problems are relatively common in pediatrics, they may not be noticed by teachers, pediatricians, and even parents. Therefore, the American Academy of Pediatrics recommends psychosocial screening as a part of the annual physical assessment for all children and adolescents. Items are scored on a scale of 0, 1, and 2 as “never,” “sometimes,” and “often,” respectively. For children aged 6 to 15, scores at or above a cutoff of 28 indicate the presence of impaired psychosocial functioning compared to most other children of the same age and the need for further professional assessment [8]. The checklist takes around 5 min to fill out. The Arabic version was used [8]. Translations were created for the California Department of Health Services, where the original PSC was developed and are available on their website [8].

B. DSM-5 criteria for ADHD [9, 10]

Children or adolescents are classified as either having primarily inattentive type of ADHD or primarily hyperactive-impulsive type or a combined diagnosis of both if criteria of both are present.

Primarily inattention type is diagnosed in the age group of 6–16 years of age if six or more symptoms of inattention have been present for at least 6 months. These include:

  • Fails to give close attention to details or makes careless mistakes in schoolwork, at work, or with other activities

  • Has trouble holding attention on tasks or play activities

  • Does not seem to listen when spoken to directly

  • Does not follow through on instructions and fails to finish schoolwork, chores, or duties in the workplace (e.g., loses focus, side-tracked)

  • Has trouble organizing tasks and activities

  • Avoids, dislikes, or is reluctant to do tasks that require mental effort over a long period of time (such as schoolwork or homework)

  • Loses things necessary for tasks and activities (e.g. school materials, pencils, books, tools, wallets, keys, paperwork, eyeglasses, mobile telephones)

  • Is easily distracted

  • Is forgetful in daily activities

Predominantly hyperactive/impulsive type is diagnosed in the age group of 6–16 years if six or more symptoms of hyperactivity-impulsivity have been present for at least 6 months.

Hyperactive symptoms include:

  • Often fidgets with or taps hands or feet, or squirms in seat

  • Often leaves seat in situations when remaining seated is expected

  • Often runs about or climbs in situations where it is not appropriate (adolescents or adults may be limited to feeling restless)

  • Often unable to play or take part in leisure activities quietly

  • Is often “on the go” acting as if “driven by a motor”

  • Often talks excessively

    Impulsive symptoms include:

  • Often blurts out an answer before a question has been completed

  • Often has trouble waiting their turn

  • Often interrupts or intrudes on others (e.g., butts into conversations or games or activities)

Combined type is diagnosed if at least 6 symptoms of both inattention and hyperactivity/impulsivity are present for at least 6 months.

Whatever the type, symptoms must be present and impair proper functioning in at least two settings (school, home, sport, etc.) and must start before reaching the age of 12 years. Also, the child must not have any other comorbid disorder that may cause such symptoms (mental, developmental, psychiatric, or sleep disorder).

The validated form of the Arabic version of DSM-5 [11] was used and was completed by the parent (mostly the mother).

C. Conners rating scale-revised, long version—parent scale

Conners Parent Rating Scale-revised (CPRS-R), long version, is an assessment tool used to detect symptoms of ADHD and to classify its' subtypes based on the parent’s observations about the youth’s behavior [12]. It is an 80-question tool, and parent responses are scored based on the frequency of occurrence of the symptom from 0 (not true or rarely true) to 3 (very true or very often true). It is completed by most parents within 20 min [13]. A standardized T score is calculated where the average scores range usually falls between 40 and 59 (within one standard deviation of mean). Scores from 60 to 64 are considered borderline or “high average” (within 1–1.5 standard deviations above mean) and require careful clinical judgment. Scores in the range of 65–69 are in the “elevated” range and usually indicate more concern than is typically reported. T scores at or above 70 (> 2 standard deviations above the mean, “very elevated” range) are very likely indicative of a significant area of concern [14].

The scale assesses a variety of behavioral problems in children and adolescents, including oppositional, cognitive problems/inattention, hyperactivity, anxious-shy, perfectionism, social problems, and psychosomatic behavioral problems. Several subscale indices are calculated from the scale, including an ADHD Index, three DSM-IV symptoms’ indices, and Conners global indices. The ADHD index is useful in identifying children and adolescents who may meet DSM-5 criteria for ADHD. There is strong evidence for ADHD when the ADHD index, the DSM Symptoms’ Indices, the Hyperactivity Subscale, and the Cognitive Problems/Inattention Subscales are all elevated [13].

It is important to note that combining information gathered from each psychometric measure together with interviews, observations, and review of available records is needed and gives the assessor a more comprehensive view of the youth than might be obtained from any one source, so that correct decisions can be made.

Statistical analysis

The collected data were revised, coded, and introduced using IBM SPSS Statistics version 17. Continuous variables were represented by the mean and standard deviation, while categorical variables were represented by percentages. Non-normally distributed variables were represented as median and interquartile ranges. Comparisons between the groups were made using an unpaired t-test, analysis of variance, or Wilcoxon signed rank tests for continuous variables and chi-squared test for categorical variables; p value of less than 0.05 was considered statistically significant.

Results

Seventy children and adolescents with type 1 diabetes and 70 age- and sex-matched controls were included in the study. There were 36 females and 34 males in the children with diabetes group and 38 females and 32 males in the control group (p = 0.73). The age of included subjects (mean ± SD) was 9.56 ± 2.25 years and 10.32 ± 2.93 years for the children and adolescents with diabetes and the controls, respectively (p = 0.088). Table 1 shows the duration of diabetes, insulin doses, and glycemic control of included patients. Unfortunately, nearly half (47.14%) of included children and adolescents with type 1 diabetes were in poor glycemic control (HbA1c > 9%) and only about one fifth (21.43%) in good control (HbA1c < 7.5%). Majority of included patients were using insulin multiple daily insulin injections (MDII) by means of insulin pens (only 10% used continuous subcutaneous insulin infusion (CSII) by means of an insulin pump). The scores and psychometric evaluation results of all participants are shown in Table 2.

Table 1 Duration of diabetes, insulin regimen and glycemic control of included children and adolescents with diabetes
Full size table
Table 2 Psychometric evaluation results of included cases with diabetes and controls
Full size table

There was a non-significant correlation between the age at onset of diabetes, diabetes duration, insulin doses, and the value of HbA1c and PSC or CPRS-R scores (p > 0.05) as shown in Table 3. Sex and category of metabolic control (good, borderline or poor) also showed a non-significant correlation with all of the psychometric assessment scores (p > 0.05).

Table 3 Correlation between the different parameters related to diabetes and the scores on the different psychometric assessment tools
Full size table

Discussion

Our study included a cross-sectional sample of children and adolescents with type 1 diabetes. The mean duration of diabetes for all included cases with diabetes was less than 5 years and most subjects had uncontrolled diabetes. A screening PSC score was significantly higher for children and adolescents with type 1 diabetes than controls (p < 0.001). Significantly larger number of children and adolescents with type 1 diabetes fulfilled DSM-5 criteria for inattentive or hyperactive or mixed type ADHD (14.3%, 17.1% and 18.6%, respectively) as compared to controls (4.3%, 5.7% and 7.1% respectively, p < 0.05). Also, a significantly larger number (more than half, 57.14%) had a Conners score above 70 and the mean scores on Conners parent rating scale were also significantly higher for cases with diabetes than controls (p < 0.001).

Our study showed a prevalence of ADHD in control children of 17.1% (for all types of ADHD) based on DSM-5 criteria. Previous studies have shown a comparable prevalence of between 16.2 and 20.9% [11, 15,16,17,18] among Egyptian children and adolescents in the age group 6–14 years, based on DSM-IV or DSM-5 (all using parent-reported data). Lower rates (~ 6.9%) were reported when primary school children were assessed using teacher reporting in addition to parent reporting [19, 20].

Regarding the prevalence among children and adolescents with type 1 diabetes, a study examining the Swedish pediatric diabetes registry between 1990 and 2013 found an increased risk for having ADHD among patients with childhood-onset type 1 diabetes (3.7% of the cohort had ADHD). The risk increased with increasing HbA1c level with the highest risk observed in those with HbA1c above 8.5% (38.1% of those with HbA1c > 8.5% had ADHD, with an adjusted odds ratio of 2.31) [4]. Based on this study as well as other studies from Sweden, it was concluded that “routine neurodevelopmental follow-up visits should be considered in type 1 diabetes, especially in patients with poor glycemic control” [5]. Moreover, in the multicentric DPV (Diabetes Prospective Follow-up Initiative) registry of pediatric type 1 diabetes in Germany/Austria, it was found that 2.83% of included children and adolescents with type 1 diabetes had ADHD as a comorbid diagnosis. In the DPV cohort, those with ADHD had higher HbA1c as compared to children and adolescents with type 1 diabetes without ADHD (mean HbA1c = 8.6% versus 7.8%, p < 0.0001) and suffered twice as often from diabetic ketoacidosis compared to patients without ADHD [21].

On the other hand, in the study of children and adolescents with type 1 diabetes diagnosed before the age of 18 years from the Danish registry [22], it was found that although there was an increased risk of psychiatric disorders, especially after 5 or more years after diagnosis, the increase in risk of development of ADHD was found non-significant when compared to the general non-diabetic control population. The significant increase was mainly found in mood disorders and anxiety, dissociative, eating, stress related and somatoform disorders, psychoactive substance misuse (in boys only), and personality disorders (in girls only) [22]. The authors noted that a possible explanation for their different results when compared to the Swedish data might be due to lack of inclusion of comorbid diagnosis of ADHD with T1DM in the Danish registry.

Compared to previous studies in children and adolescents with type 1 diabetes in European countries, our results showed a higher percentage of children and adolescents with type 1 diabetes with ADHD (between 14.3 and 18.6% based on DSM-5 criteria with 57.14% having Conners score in the ADHD diagnostic range). A possible explanation might be due to the poor metabolic control among most of our included patients with only 21.13% having HbA1c below 7.5%, which is still not the optimum target.

Moreover, it is important to note that for ADHD diagnosis, it is important to document impairment of normal functioning in two different settings (home, school, sports, etc.) [9]. Therefore, our study needs to further evaluate these children and adolescents by a second informant, for example a teacher. Several studies (from Egypt and worldwide) have shown that parents report ADHD symptoms more frequently than teachers [19, 20, 23,24,25,26,27,28,29] and that parents may not have age-appropriate behavioral expectations for their children causing overdiagnosis of ADHD. Parents were found to be more reliable in ratings of forgetfulness, whereas teachers were found to be more reliable reporters of deficits in sustained attention (teachers can quickly compare students and detect those poorly performing in a class task) [23, 30]. In addition, mothers (the main informants in our study) were found to consistently report more inattention and hyperactivity symptoms than fathers (mothers spend longer times with children than fathers and many children behave better in the presence of their father) [23, 24, 28, 31].

The much higher percentage of possible ADHD children detected by Conners score in our study (57.14% scored above 70) may be due to the high sensitivity of CPRS-R in detecting ADHD but its relative poor specificity [29, 32, 33]. Clinician-based rating of ADHD symptoms based on a semi-structured parent interview was found to have superior sensitivity compared to parent-filled out CPRS-R questionnaires [29].

A recent systematic review found that overdiagnosis of ADHD may occur due to diagnostic inflation with the newer criteria for diagnosis which widened the definition of ADHD to include ambiguous or mild symptoms, and in patients with those symptoms, harms may outweigh the small benefits of treatment [34]. For such mild cases of ADHD, experts have suggested a stepped approach for diagnosis to avoid overdiagnosis without missing real cases. In this approach, baseline information is collected from several sources first, explanations for behavioral problems are sought (sleep deprivation, challenges/tensions in school or home, etc.), and then watchful waiting is done with monitoring and follow-up without active treatment. Then, if the problems persist, help is offered in the form of brochures or parent training on how to deal with hyperactive children. This is done without using the term ADHD but rather referring to the child as having “concentration problem, restlessness or behavioral problem”. If minimal intervention is not enough and problems persist, a short 5–6 session counseling is offered to teach attitudes and coping skills in dealing with hyperactivity, concentration impairment. If problems still persist, referral to secondary care (psychiatrist or developmental pediatrician) for definitive diagnosis and proper treatment is advised [34].

Despite all of the above factors and given that the percentage of ADHD of our control arm compares to that of several previous studies among non-diabetic children and adolescents, our results show an alarming prevalence of ADHD among children and adolescents with type 1 diabetes based on all the three different methods of assessment carried out. Based on the standardized DSM-5 criteria, a significant difference was evident between cases with type 1 diabetes and control subjects (a prevalence of 14.3–18.6% versus 4.3-–7.1%, p < 0.05). It was surprising to find such a high percentage of individuals likely having ADHD; only two patients are being followed in the childhood psychiatry clinic, but none of the rest is following up in a psychiatry clinic or is aware of the need for further evaluation by a psychiatrist.

Unlike previous studies which were mainly longitudinal studies based on different European registries, our study is a cross-sectional one that aimed to screen for the presence of ADHD among a sample of children and adolescents with type 1 diabetes as compared to controls. Egypt is a developing country with higher poverty levels compared to Sweden, Germany, and Austria. A major problem in Egypt (and as such in other developing countries) is that parents are busy working day and night striving to provide the daily living. Together with lack of awareness of ADHD, the diagnosis may easily be missed. Also, not every diabetes clinic has a psychiatrist working as an integral part of the multidisciplinary team of the clinic, but rather when a need is spotted, the patient is referred to a psychiatrist/psychiatric clinic (as is done at our university hospital clinic). This may also cause delay and missing of the diagnosis of neuropsychological disorders such as ADHD, which reflects on both glycemic control and the underlying disorder.

Early diagnosis of ADHD among children and adolescents with diabetes is important as ADHD patients may miss/miscalculate insulin doses due to inattention or forgetfulness. Also, in those with hyperactivity, there will be an increased risk of hypoglycemia that must be put into consideration when designing their insulin therapy. Both these factors may result in poor glycemic control which is also known to cause neuro-psychological functional impairment, resulting in a vicious circle. The longer the duration of delay in diagnosis, the worse will be the glycemic control [35]. The diagnosis of diabetes itself adds extra stress to ADHD patients. Moreover, patients with ADHD may need different educational material for their diabetes management with the use of more pictures to overcome their easy distractibility [36]. They would also need more frequent visits as compared to non-ADHD patients. In our study, although no correlation was found between scores on ADHD testing and HbA1c value, it is likely that this is because glycemic control in the majority of our patients was inadequate with only about one fifth achieving good control.

Conclusion

In conclusion, our study indicates a real need to evaluate children and adolescents with type 1 diabetes for ADHD, especially those in poor metabolic control. This is important so that insulin therapy can be properly instituted (while accounting for the risk of hypoglycemia or hyperglycemia with inattention, forgetfulness, and hyperactivity) and proper educational material can be used (with more use of pictures in handouts, toolkits and educational videos). In addition, ADHD management would be more properly carried out, given the risks of neuropsychological dysfunction associated with fluctuations in blood sugar. Further larger scale studies may explore the pathophysiologic/etiologic link between type 1 diabetes and ADHD.

Our study is not without limitations. One limitation is that parent questionnaire data was mainly based on parent reporting (mainly by mothers), no teacher or other informant reporting was obtained, and no semi-structured interviews were carried out. Yet, it also has several strengths. It represents the first evaluation for the neuro-behavioral disorder of ADHD in our diabetes clinic. Also, evaluation for ADHD was carried out using multiple different ways: the PSC (the long 35-item form), DSM-5 criteria, and CPRS-R (the long 80-item form). In addition, our study included a control group so that factors affecting the patient arm would equally affect the control arm.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

References

  1. Rocco I, Corso B, Bonati M, Minicuci N (2021) Time of onset and/or diagnosis of ADHD in European children: a systematic review. BMC Psychiatry 21:575. https://doi.org/10.1186/s12888-021-03547-x

    Article  Google Scholar 

  2. American Psychiatric Association (2013) Attention-deficit/hyperactivity disorder. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. American Psychiatric Association, Arlington, VA, p 59

    Chapter  Google Scholar 

  3. Faraone SV, Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, Rohde LA, Sonuga-Barke EJS, Tannock R, Franke B (2015) Attention-deficit/hyperactivity disorder. Nat Rev Dis Primers 1:1–23. https://doi.org/10.1038/nrdp.2015.20

    Article  Google Scholar 

  4. Liu S, Kuja-Halkola R, Larsson H, Lichtenstein P, Ludvigsson JF, Svensson A, Gudbjörnsdottir S, Tideman M, Serlachius E, Butwicka A (2021) Neurodevelopmental disorders, glycemic control, and diabetic complications in type 1 diabetes: a nationwide cohort study. J Clin Endocrinol Metab 106(11):e4459–e4470. https://doi.org/10.1210/clinem/dgab467

    Article  Google Scholar 

  5. Nylander C, Fernell E (2021) ADHD should be considered in adolescents with type 1 diabetes and poor metabolic control. Diabetologia 64(8):1897–1898. https://doi.org/10.1007/s00125-021-05493-5

    Article  Google Scholar 

  6. Butwicka A, Frisén L, Almqvist C, Zethelius B, Lichtenstein P (2015) Risks of psychiatric disorders and suicide attempts in children and adolescents with type 1 diabetes: a population-based cohort study [published correction appears in Diabetes Care 2016 Mar; 39(3):495]. Diabetes Care 38(3):453–459. https://doi.org/10.2337/dc14-0262

    Article  Google Scholar 

  7. DiMeglio LA, Acerini CL, Codner E et al (2018) ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes 19(Suppl. 27):105–114. https://doi.org/10.1111/pedi.12737

    Article  Google Scholar 

  8. Pediatric Symptom Checklist. Available at: https://www.massgeneral.org/psychiatry/treatments-and-services/pediatric-symptom-checklist. Last accessed 21 May 2022.

  9. Wolraich ML, Hagan JF, Allan C, Chan E, Davison D, Earls M, Evans SW, Flinn SK, Froehlich T, Frost J, Holbrook JR, Lehmann CU, Lessin HR, Okechukwu K, Pierce KL, Winner JD, Zurhellen W (2019) American Academy of Pediatrics (AAP) subcommittee on children and adolescents with attention-deficit/hyperactive disorder. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 144(4):e20192528. https://doi.org/10.1542/peds.2019-2528 (Erratum in: Pediatrics. 2020 Mar;145(3): PMID: 31570648; PMCID: PMC7067282)

    Article  Google Scholar 

  10. DSM-5 ADHD Symptom Checklist. Available at: https://chsciowa.org/sites/chsciowa.org/files/resource/files/1_-_adhd_dsm-5_checklist.pdf

  11. Aboul-ata MA, Amin FA (2018) The prevalence of ADHD in Fayoum City (Egypt) among school-age children: depending on a DSM-5-based rating scale. J Atten Disord 22(2):127–133. https://doi.org/10.1177/1087054715576917

    Article  Google Scholar 

  12. Abo Elella E, Hassan GA, Sabry W, Hendawy H, Shorub E, Zyada F, Medany O (2017) Trait emotional intelligence in a sample of Egyptian children with attention deficit hyperactivity disorder. Child Adolesc Ment Health, 22:216-223. https://doi.org/10.1111/camh.12236

  13. Conners K, Sitarenios G, Parker J, Epstein J (1998) The revised Conners’ Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 26:257–268

    Article  CAS  Google Scholar 

  14. Conners Comprehensive Behavior Rating Scales™ Supplement. Conners CBRS Update, April 2009. Available at: https://www.acer.org/files/CBRS-Supplement.pdf.

  15. El-Gendy SD, El-Bitar EA, El-Awady MA, Bayomy HE, Agwa EM (2017) Attention-deficit/hyperactivity disorder: prevalence and risk factors in Egyptian primary school children. Egyptian J Commun Med 35(1):1–16

    Article  Google Scholar 

  16. El-Nemr FM, Badr HS, Salem MS (2015) Prevalence of attention deficit hyperactivity disorder in children. Sci J Public Health 3:274–280

    Article  Google Scholar 

  17. El-Sayed R, El-Mogy M, Ali H, Ghowinam MMA (2018) Prevalence of ADHD symptoms among a sample of Egyptian school age children. Med J Cairo Univ 86(3):1719–1725

    Google Scholar 

  18. Al-Haggar M, El-Baz R, Youseff H, Othman N, Ali R (2006) Overview on attention deficit hyperactivity disorder among children from Delta regions of Egypt (a 10 years-study). J Pediatr Neurol 4:15–18

    Google Scholar 

  19. Farahat T, Alkot M, Rajab A, Anbar R (2014) Attention deficit hyperactive disorder among primary school children in Menoufia governorate. Egypt Int J Fam Med 2014:257369. https://doi.org/10.1155/2014/257369

    Article  Google Scholar 

  20. Soliman GT, Afify MF, Yehia MA, Abdel-Naem EA, Abd Alkarim SM (2010) Attention deficit hyperactivity disorders: an epidemiological study of preschool and primary school children in Minia city. El-Minia Medical Bulletin 21:171–179

    Google Scholar 

  21. Hilgard D, Konrad K, Meusers M, Bartus B, Otto KP, Lepler R, Schober E, Bollow E, Holl RW, German/Austrian DPV Study Group, the Working Group on Psychiatric, Psychotherapeutic Psychological Aspects of PaediatricDiabetology (PPAG e.V.) and the BMBF Competence Network Diabetes, Germany (2017) Comorbidity of attention deficit hyperactivity disorder and type 1 diabetes in children and adolescents: analysis based on the multicentre DPV registry. Pediatr Diabetes 18(8):706–713. https://doi.org/10.1111/pedi.12431 (Epub 2016 Aug 15 PMID: 27523391)

    Article  CAS  Google Scholar 

  22. Dybdal D, Tolstrup JS, Sildorf SM, Boisen KM, Svensson J, Skovgaard AM, Teilmann GK (2018) Increasing risk of psychiatric morbidity after childhood onset type 1 diabetes: a population-based cohort study. Diabetologia 61:831–838. https://doi.org/10.1007/s00125-017-4517-7

    Article  Google Scholar 

  23. Caye A, Machado JD, Rohde LA (2013) Evaluating parental disagreement in ADHD diagnosis: can we rely on a single report from home? J Atten Disord 21(7):561–566. https://doi.org/10.1177/1087054713504134

    Article  Google Scholar 

  24. Moraes PCB, Damásio BF, de Lima GCM, Sudo FK, de Mattos PEL (2020) Parent-teacher report reliability on the fourth edition of the Swanson, Nolan and Pelham scale in a Brazilian clinical sample of children and adolescents with attention-deficit/hyperactivity disorder. Arc Clin Psychiatr 47(2):35–39. https://doi.org/10.1590/0101-60830000000228

    Article  Google Scholar 

  25. Kennerley S, Jaquiery B, Hatch B, Healey M, Wheeler BJ and Healey D. Informant discrepancies in the assessment of attention deficit/hyperactivity disorder. J Psychoeduc Assess. 2016;1–12. https://doi.org/10.1177/0734282916670797.

  26. Narad M, Garner A, Peugh J, Tamm L, Antonini T, Kingery K, Simon JO, Epstein JN (2015) Parent teacher agreement on ADHD symptoms across development. Psychol Assess 27(1):239–248. https://doi.org/10.1037/a0037864

    Article  Google Scholar 

  27. Takeda T, Nissley-Tsiopinis J, Nanda S and Eiraldi R. Factors associated with discrepancy in parent–teacher reporting of symptoms of ADHD in a large clinic-referred sample of children. J Atten Disord. 2016; 1–11. https://doi.org/10.1177/1087054716652476.

  28. Wan Ismail WS, Nik Jaafar NR and Baharudin A. Disagreement across the parents, teachers and adolescents in reporting attention deficit hyperactivity disorder (ADHD) symptoms: what have we learned? Medical Research Archives 2017;5(4). ISSN 2375–1924. Available at: https://esmed.org/MRA/mra/article/view/1177.

  29. Nobel E, Brunnekreef JA, Schachar RJ, van den Hoofdakker BJ, Hoekstra PJ (2019) Parent–clinician agreement in rating the presence and severity of attention-deficit/hyperactivity disorder symptoms. ADHD 11(1):21–29. https://doi.org/10.1007/s12402-018-0267-8

    Article  Google Scholar 

  30. Garcia-Rosales A, Vitoratou S, Faraone SV, Rudaizky D, Banaschewski T, Asherson P, Sonuga-Barke E, Buitelaar J, Oades RD, Rothenberger A, Steinhausen HC, Taylor E, Chen W (2021) Differential utility of teacher and parent-teacher combined information in the assessment of Attention Deficit/Hyperactivity Disorder symptoms. Eur Child Adolesc Psychiatry 30(1):143–153. https://doi.org/10.1007/s00787-020-01509-4 (Epub 2020 Apr 3. PMID: 32246275; PMCID: PMC7864845)

    Article  Google Scholar 

  31. Sollie H, Larsson B, Mørch WT (2013) Comparison of mother, father, and teacher reports of ADHD core symptoms in a sample of child psychiatric outpatients. J Atten Disord 17(8):699–710. https://doi.org/10.1177/1087054711436010 (Epub 2012 Mar 21 PMID: 22441890)

    Article  Google Scholar 

  32. Parker A, Corkum P (2016) ADHD diagnosis: as simple as administering a questionnaire or a complex diagnostic process? J Atten Disord 20(6):478–486. https://doi.org/10.1177/1087054713495736 (Epub 2013 Jul 25 PMID: 23887860)

    Article  Google Scholar 

  33. Swanson JM, Wigal T, Lakes K (2009) DSM-V and the future diagnosis of attention-deficit/hyperactivity disorder. Curr Psychiatry Rep 11(5):399–406. https://doi.org/10.1007/s11920-009-0060-7

    Article  Google Scholar 

  34. Kazda L, Bell K, Thomas R, McGeechan K, Sims R, Barratt A (2021) Overdiagnosis of attention-deficit/hyperactivity disorder in children and adolescents: a systematic scoping review. JAMA Netw Open 4(4):e215335. https://doi.org/10.1001/jamanetworkopen.2021.5335.PMID:33843998;PMCID:PMC8042533

    Article  Google Scholar 

  35. Mazor-Aronovitch K, Pinhas-Hamiel O, Pivko-Levy D, Modan-Moses D, Levek N, Miller S, Yackobovitch-Gavan M, Gruber N, Ben-Ami M, Stern E, Ben-Ari T, Graf-Barel C, Frumkin Ben-David R, Levy-Shraga Y, Landau Z (2021) Dual diagnosis of type 1 diabetes mellitus and attention deficit hyperactivity disorder. Pediatr Diabetes 22(4):649–655. https://doi.org/10.1111/pedi.13195 (Epub 2021 Mar 9 PMID: 33651452)

    Article  CAS  Google Scholar 

  36. Sjoberg S, Edgren M, Gutefeldt K (2016) Type 1 diabetes and attention deficit hyperkinetic disorder: development of new educational material. Endocrine Abstracts. 41:GP103. https://doi.org/10.1530/endoabs.41.GP103

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

No funding or financial or material support from any funding agency in the public, commercial, or not-for-profit sectors was received for the work included in this manuscript.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Pediatric Diabetology, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    Hanan Hassan Aly

  2. Department of Pediatrics, Division of Pediatric Psychiatry, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    Eman Amin AbdelAziz & Batoul Mohamed AbdelRaouf

  3. Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    Mohamed Abdullah Mousa

Authors
  1. Hanan Hassan Aly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eman Amin AbdelAziz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohamed Abdullah Mousa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Batoul Mohamed AbdelRaouf
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Eman A AbdelAziz, Hanan H Aly, and Batoul M AbdelRaouf conceptualized, designed, and together with Mohamed A Mousa conducted the study. Mohamed A Mousa did the data acquisition. All authors contributed to the literature review. Batoul M AbdelRarouf revised the questionnaires. Hanan H Aly wrote the final manuscript. All authors revised and approved the submitted manuscript and agreed to publish it in the Egyptian Pediatric Association Gazette.

Corresponding author

Correspondence to Hanan Hassan Aly.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the Research Ethical Committee of Pediatric Department, Faculty of Medicine, Ain Shams University. Informed written consents were obtained from the participants’ guardians and adolescent participants prior to the inclusion in the study. Ethical approval was obtained from the Research Ethics Committee at the Faculty of Medicine (Ethical Committee No. FMASU R 568/2020).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aly, H.H., AbdelAziz, E.A., Mousa, M.A. et al. Attention-deficit hyperkinetic disorder among children and adolescents with type 1 diabetes: a cross-sectional study. Egypt Pediatric Association Gaz 70, 54 (2022). https://doi.org/10.1186/s43054-022-00147-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43054-022-00147-6

Keywords